The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress.

Coates, James T T; Rodriguez-Berriguete, Gonzalo; Puliyadi, Rathi; Ashton, Thomas; Prevo, Remko; Wing, Archie; Granata, Giovanna; Pirovano, Giacomo; McKenna, Gillies W; Higgins, Geoff S

Coates, James T T; Rodriguez-Berriguete, Gonzalo; Puliyadi, Rathi; Ashton, Thomas; Prevo, Remko; Wing, Archie; Granata, Giovanna; Pirovano, Giacomo; McKenna, Gillies W; Higgins, Geoff S.

Afiliación

Coates JTT; Department of Oncology, University of Oxford, Oxford, UK.
Rodriguez-Berriguete G; Department of Oncology, University of Oxford, Oxford, UK.
Puliyadi R; Department of Oncology, University of Oxford, Oxford, UK.
Ashton T; Department of Oncology, University of Oxford, Oxford, UK.
Prevo R; Department of Oncology, University of Oxford, Oxford, UK.
Wing A; Department of Oncology, University of Oxford, Oxford, UK.
Granata G; Department of Oncology, University of Oxford, Oxford, UK.
Pirovano G; Department of Oncology, University of Oxford, Oxford, UK.
McKenna GW; Department of Oncology, University of Oxford, Oxford, UK.
Higgins GS; Department of Oncology, University of Oxford, Oxford, UK.

Cell Death Discov ; 6: 110, 2020.

Article en En | MEDLINE | ID: mdl-33133645

Palabras clave

Chemotherapy; Preclinical research

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Death Discov Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google